Thyroid Cancer
Molecular knowledge explains response in differentiated thyroid cancer
‘True rise’ in thyroid cancer incidence, related mortality observed in California

CHICAGO — From 2000 to 2012, men with thyroid cancer and individuals with larger thyroid tumors experienced greater cancer-related mortality, and adults were diagnosed with thyroid cancers of all types at higher rates, according to findings presented at the annual meeting of the American Thyroid Association.
Emerging thyroid cancer test may prevent unnecessary surgeries

Thyroid cancer is among the most curable types of cancer, with relative survival rates close to 100% for localized and regional tumors. Incidence of the malignancy has increased rapidly, with about 52,000 new cases diagnosed each year in the United States, according to American Cancer Society data. Fine-needle aspiration, which is the current standard in thyroid cancer diagnostics, yields inconclusive results in about one of every five cases. In these cases, patients often undergo a follow-up genetic test, which is prone to false-positive results. This may prompt surgical intervention, which can lead to lifetime hormone replacement therapy and other repercussions and ultimately may prove unnecessary. FNA [fine-needle aspiration] samples based on cytology is very challenging, and thyroid surgery may be required for the final diagnosis,” Jialing Zhang, PhD, research associate at The University of Texas at Austin, said in an interview with HemOnc Today. “However, in the majority of these surgical cases, the lesion is found to be benign on final histopathology, and the diagnostic surgery was therefore possibly unnecessary.”
Annual meeting highlights latest treatments, advances in thyroid care

Attendees heading to this year’s annual meeting of the American Thyroid Association can expect to learn about the latest advances in thyroidology while taking part in educational, networking and professional development opportunities that foster collaboration and discussion of cutting-edge research.
Radioactive iodine treatment not linked to adverse pregnancy outcomes at 6 months
Patient preference for maximal thyroid cancer surveillance linked to increased use of resources
Unique thyroid nodule procedure provides benefit without hassle
Age mediates obesity’s influence on thyroid cancer risk
Pediatric thyroid tumor evaluation should include microscopic extrathyroidal extension
Endocrine Today cover stories
Each month Endocrine Today reporters delve deep into a topic of current interest. These longform cover stories provide background and insights from leading researchers and clinicians. All of these features can be found under the opinion tab above and at the links below. Stories published so far in 2019 include emerging alternatives in thyroid cancer treatment, promising developments in beta-cell regeneration, questions about vitamin D’s effectiveness, and more.